210 related articles for article (PubMed ID: 12010989)
1. Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin B.
Hale ML; Margolin SB; Krakauer T; Roy CJ; Stiles BG
Infect Immun; 2002 Jun; 70(6):2989-94. PubMed ID: 12010989
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release.
Krakauer T; Stiles BG
Clin Diagn Lab Immunol; 1999 Jul; 6(4):594-8. PubMed ID: 10391869
[TBL] [Abstract][Full Text] [Related]
3. Increased mortality and impaired clonal deletion after staphylococcal enterotoxin B injection in old mice: relation to cytokines and nitric oxide production.
Kuschnaroff LM; Goebels J; Valckx D; Heremans H; Matthys P; Waer M
Scand J Immunol; 1997 Nov; 46(5):469-78. PubMed ID: 9393629
[TBL] [Abstract][Full Text] [Related]
4. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
5. Superantigen and endotoxin synergize in the induction of lethal shock.
Blank C; Luz A; Bendigs S; Erdmann A; Wagner H; Heeg K
Eur J Immunol; 1997 Apr; 27(4):825-33. PubMed ID: 9130631
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor necrosis factor and subsequent endotoxin shock by pirfenidone.
Cain WC; Stuart RW; Lefkowitz DL; Starnes JD; Margolin S; Lefkowitz SS
Int J Immunopharmacol; 1998 Dec; 20(12):685-95. PubMed ID: 9877280
[TBL] [Abstract][Full Text] [Related]
7. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.
Miethke T; Wahl C; Heeg K; Echtenacher B; Krammer PH; Wagner H
J Exp Med; 1992 Jan; 175(1):91-8. PubMed ID: 1730929
[TBL] [Abstract][Full Text] [Related]
8. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines.
Tokura Y; Yagi J; O'Malley M; Lewis JM; Takigawa M; Edelson RL; Tigelaar RE
J Invest Dermatol; 1994 Jan; 102(1):31-8. PubMed ID: 8288908
[TBL] [Abstract][Full Text] [Related]
9. Effect of treatments with cyclosporin A and anti-interferon-gamma antibodies on the mechanisms of immune tolerance in staphylococcal enterotoxin B primed mice.
Kuschnaroff LM; Valckx D; Goebels J; Rutgeerts O; Heremans H; Froyent G; Waer M
Scand J Immunol; 1997 Nov; 46(5):459-68. PubMed ID: 9393628
[TBL] [Abstract][Full Text] [Related]
10. A highly neutralizing human monoclonal antibody targeting a novel linear epitope on staphylococcal enterotoxin B.
Fan H; Zhao L; Wang W; Yu F; Jing H; Yang Y; Zhang X; Zhao Z; Gou Q; Zhang W; Zou Q; Zhang J; Zeng H
Hum Vaccin Immunother; 2024 Dec; 20(1):2360338. PubMed ID: 38857905
[TBL] [Abstract][Full Text] [Related]
11. Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock.
Oku H; Nakazato H; Horikawa T; Tsuruta Y; Suzuki R
Eur J Pharmacol; 2002 Jun; 446(1-3):167-76. PubMed ID: 12098599
[TBL] [Abstract][Full Text] [Related]
12. Cytokine secretion induced by superantigens in peripheral blood mononuclear cells, lamina propria lymphocytes, and intraepithelial lymphocytes.
Sperber K; Silverstein L; Brusco C; Yoon C; Mullin GE; Mayer L
Clin Diagn Lab Immunol; 1995 Jul; 2(4):473-7. PubMed ID: 7583927
[TBL] [Abstract][Full Text] [Related]
13. A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-alpha at the translational level.
Nakazato H; Oku H; Yamane S; Tsuruta Y; Suzuki R
Eur J Pharmacol; 2002 Jun; 446(1-3):177-85. PubMed ID: 12098600
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo.
Krakauer T; Buckley M; Issaq HJ; Fox SD
Antimicrob Agents Chemother; 2010 Mar; 54(3):1125-31. PubMed ID: 20086156
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model.
Woody MA; Krakauer T; Stiles BG
Vaccine; 1997 Feb; 15(2):133-9. PubMed ID: 9066029
[TBL] [Abstract][Full Text] [Related]
16. Comparative inflammatory properties of staphylococcal superantigenic enterotoxins SEA and SEG: implications for septic shock.
Dauwalder O; Thomas D; Ferry T; Debard AL; Badiou C; Vandenesch F; Etienne J; Lina G; Monneret G
J Leukoc Biol; 2006 Oct; 80(4):753-8. PubMed ID: 16885504
[TBL] [Abstract][Full Text] [Related]
17. Differential cytokine response in host defence mechanisms triggered by gram-negative and gram-positive bacteria, and the roles of gabexate mesilate, a synthetic protease inhibitor.
Iwadou H; Morimoto Y; Iwagaki H; Sinoura S; Chouda Y; Kodama M; Yoshioka T; Saito S; Yagi T; Tanaka N
J Int Med Res; 2002; 30(2):99-108. PubMed ID: 12025532
[TBL] [Abstract][Full Text] [Related]
18. Determination of C5a in murine models of staphylococcal enterotoxin B-induced toxic shock.
Krakauer T
J Immunoassay Immunochem; 2013; 34(1):30-8. PubMed ID: 23323979
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide regulates clonal expansion and activation-induced cell death triggered by staphylococcal enterotoxin B.
Brás A; Rodríguez-Borlado L; González-Garcia A; Martínez-A C
Infect Immun; 1997 Oct; 65(10):4030-7. PubMed ID: 9317003
[TBL] [Abstract][Full Text] [Related]
20. The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice.
Florquin S; Amraoui Z; Dubois C; Decuyper J; Goldman M
J Exp Med; 1994 Sep; 180(3):1153-8. PubMed ID: 7520469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
